Showing results (131-140 of 217) with videos related to

Sort By:
Pageof 22
Urologic Oncology|April 9, 2013
Phase II trial of first-line chemotherapy with gemcitabine, etoposide, and cisplatin for patients with advanced urothelial carcinomaShinji Urakami, Yasuhisa Fujii, Shinya Yamamoto, et al.
The Journal of Urology|October 22, 2008
Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancerNorihiko Tsuchiya, Takamitsu Inoue, Shintaro Narita, et al.
Urology|November 11, 2006
Radical nephroureterectomy as initial treatment for carcinoma in situ of upper urinary tractTakeshi Yuasa, Norihiko Tsuchiya, Shintaro Narita, et al.
Urologia Internationalis|September 16, 2009
Cystoprostatectomy as a treatment of prostate cancer involving the bladder neckTeruaki Kumazawa, Norihiko Tsuchiya, Mitsuru Saito, et al.
Human Immunology|March 24, 2005
Human leukocyte antigens in Japanese patients with biliary atresia: retrospective analysis of patients who underwent living donor liver transplantationTakeshi Yuasa, Hiroaki Tsuji, Shinya Kimura, et al.
Cancer Science|February 18, 2004
p53-independent anti-tumor effects of the nitrogen-containing bisphosphonate zoledronic acidJunya Kuroda, Shinya Kimura, Hidekazu Segawa, et al.
Urologia Internationalis|August 19, 2011
Outcome of antegrade radical prostatectomy with intended wide resection in prostate cancer patients with a preoperative serum PSA level >100 ng/mlShinji Urakami, Junji Yonese, Shinya Yamamoto, et al.
International Journal of Clinical Oncology|June 28, 2011
Outcome, clinical prognostic factors and genetic predictors of adverse reactions of intermittent combination chemotherapy with docetaxel, estramustine phosphate and carboplatin for castration-resistant prostate cancerShintaro Narita, Norihiko Tsuchiya, Takeshi Yuasa, et al.
Oncology Reports|October 5, 2007
Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancerHisami Fukuda, Norihiko Tsuchiya, Shintaro Narita, et al.
BMC Cancer|August 8, 2008
A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancerNaofumi Narita, Takeshi Yuasa, Norihiko Tsuchiya, et al.
Pageof 22